Study Name: A Study Of Oral PF-02341066, A c-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer
11 locations found
- Pfizer Investigational Site
Location: Boston, Massachusetts 02114
- Pfizer Investigational Site
Location: Boston, Massachusetts 02115
- Pfizer Investigational Site
Location: New York, New York 10021
- Pfizer Investigational Site
Location: New York, New York 10022
- Pfizer Investigational Site
Location: Southfield, Michigan 48034
- Pfizer Investigational Site
Location: Warren, Michigan 48093
- Pfizer Investigational Site
Location: Dearborn, Michigan 48124
- Pfizer Investigational Site
Location: Detroit, Michigan 48201
- Pfizer Investigational Site
Location: Chicago, Illinois 60637
- Pfizer Investigational Site
Location: Aurora, Colorado 80045
- Pfizer Investigational Site
Location: Orange, California 92868
|